Shelton Capital Management Gsk PLC Transaction History

Shelton Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $434,839 - $493,989	-10,341 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$32.47 - $48.83 $8,442 - $12,695	260 Added 2.58%	10,341 $392,000
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $380,604 - $412,482	9,660 Added 2294.54%	10,081 $403,000
Q1 2019 May 10, 2019	SELL	$38.57 - $42.69 $372,586 - $412,385	-9,660 Reduced 95.82%	421 $10.1 Million
Q4 2018 Jan 31, 2019	SELL	$37.8 - $42.69 $158,760 - $179,298	-4,200 Reduced 29.41%	10,081 $385,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $211,668 - $227,324	-5,325 Reduced 27.16%	14,281 $574,000
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $776,593 - $838,352	19,606 New	19,606 $790,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $98,590 - $109,408	-2,725 Reduced 12.2%	19,606 $766,000
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $1 Million - $1.19 Million	-28,331 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $473,280 - $498,599	12,000 Added 73.48%	28,331 $1.15 Million
Q3 2016 Dec 06, 2017	BUY	N/A	16,331 New	16,331 $704,000
Q3 2016 Dec 04, 2017	BUY	N/A	16,331	16,331 $629,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.